Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-09-3056PMID 14670917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation.

  2003cited by this paper
• Restoration of CD28 Expression in CD28− CD8+ Memory Effector T Cells Reconstitutes Antigen-induced IL-2 Production

  2003cited by this paper
• Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

  2002cited by this paper
• Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals.

  2002cited by this paper
• High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.

  2002cited by this paper
• Efficient Generation of Antigen-Specific Cytotoxic T Cells Using Retrovirally Transduced CD40-Activated B Cells1

  2002cited by this paper
• Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance

  2002cited by this paper
• Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.

  2002cited by this paper
• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

  2002cited by this paper
• Isolation and expansion of human cytomegalovirus- specific cytotoxic T lymphocytes using interferon-gamma secretion assay.

  2002cited by this paper
• Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype.

  2002cited by this paper
• Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions.

  2001cited by this paper
• Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.

  2001cited by this paper
• Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

  2001cited by this paper
• Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay

  2001cited by this paper
• Haploidentical stem cell transplantation in leukemia.

  2001cited by this paper
• Ex vivo generation of human cytomegalovirus‐specific cytotoxic T cells by peptide‐pulsed dendritic cells

  2001cited by this paper
• Infrequent Occurrence of Natural Mutations in the pp65495–503 Epitope Sequence Presented by the HLA A∗0201 Allele among Human Cytomegalovirus Isolates

  2001cited by this paper
• Selective ex vivo expansion of cytomegalovirus‐specific CD4+ and CD8+ T lymphocytes using dendritic cells pulsed with a human leucocyte antigen A*0201‐restricted peptide

  2001cited by this paper
• Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

  2000cited by this paper
• Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes.

  2000cited by this paper
• Rapid selection of antigen-specific T lymphocytes by retroviral transduction.

  2000cited by this paper
• Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts.

  1999cited by this paper
• Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.

  1999cited by this paper
• Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients.

  1999cited by this paper
• Enrichment and detection of live antigen‐specific CD4+ and CD8+ T cells based on cytokine secretion

  1999cited by this paper
• Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.

  1997cited by this paper
• Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes

  1996cited by this paper
• PCR activity of CMV in healthy CMV-seropositive individuals: does latency need redefinition?

  1996cited by this paper
• Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product

  1996cited by this paper
• Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation.

  1995cited by this paper
• Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

  1995cited by this paper
• Cytomegalovirus reactivation and tumour necrosis factor.

  1994cited by this paper
• Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.

  1992cited by this paper
• Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group.

  1992cited by this paper
• Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

  1991cited by this paper
• LYMPHOCYTE RESPONSES AFTER CYTOMEGALOVIRUS INFECTION IN BONE MARROW TRANSPLANT RECIPIENTS—A ONE‐YEAR FOLLOW‐UP

  1985cited by this paper

• Unveiling signaling pathways inducing MHC class II expression in neutrophils

  2024cites this paper
• Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo

  2024cites this paper
• EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation

  2024cites this paper
• Qualitative evaluation of connective tissue disease with cytomegalovirus infection: A meta-analysis of case reports.

  2024cites this paper
• Dynamic monitoring of viral gene expression reveals rapid antiviral effects of CD8 T cells recognizing the HCMV-pp65 antigen

  2023cites this paper
• Stem cell memory EBV-specific T cells control post-transplant lymphoproliferative disease and persist in vivo

  2023cites this paper
• A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications

  2022cites this paper
• Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation

  2022cites this paper
• THE GENERATION AND APPLICATION OF ANTIGEN-SPECIFIC T CELL THERAPIES FOR CANCER AND VIRAL-ASSOCIATED DISEASE.

  2022cites this paper
• Adoptive therapy with cytomegalovirus‐specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy

  2022cites this paper
• Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities

  2022cites this paper
• Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of Leukemia

  2022cites this paper
• Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions

  2022cites this paper
• Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?

  2021cites this paper
• Immunotherapy with adoptive cytomegalovirus‐specific T cells transfer: Summarizing latest gene engineering techniques

  2021cites this paper
• Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19

  2021cites this paper
• Chimeric Antigen Receptors Targeting Human Cytomegalovirus.

  2020cites this paper
• Δ42PD1-TLR4 Augments γδ-T Cell Activation of the Transitional Memory Subset of CD4+ T Cells

  2020cites this paper
• Rapid GMP-compliant expansion of SARS-CoV-2-specific T cells from convalescent donors for use as an allogeneic cell therapy for COVID-19

  2020cites this paper
• A simple and efficient method of generating HCMV pp65-specific T cells using overlapping peptides.

  2020cites this paper
• Impact of TCR-ligand avidity for viral and tumor antigens on human CD8 T cell potency and long-term persistence

  2019cites this paper
• Control of cytomegalovirus viremia after T cell depleted allogeneic stem cell transplantation

  2019cites this paper
• Control of Cytomegalovirus Viremia after Allogeneic Stem Cell Transplantation: A Review on CMV-Specific T Cell Reconstitution.

  2018cites this paper
• Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4+ and CD8+ T Cell Responses against Mouse Cytomegalovirus Infection

  2017cites this paper
• Preservation of Antigen-Specific Functions of αβ T Cells and B Cells Removed from Hematopoietic Stem Cell Transplants Suggests Their Use As an Alternative Cell Source for Advanced Manipulation and Adoptive Immunotherapy

  2017cites this paper
• Robust Production of Cytomegalovirus pp65-Specific T Cells Using a Fully Automated IFN-γ Cytokine Capture System

  2017cites this paper
• Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus

  2017cites this paper
• Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens

  2016cites this paper
• Adoptive Immunotherapy for Infection Control Using Antigen-Specific Donor-Derived T Cells After Transplantation

  2016cites this paper
• Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy

  2016cites this paper
• Comparative Analysis of Clinical-Scale IFN-γ-Positive T-Cell Enrichment Using Partially and Fully Integrated Platforms

  2016influential citation
• Cytomegalovirus-Specific T Cells Isolated by IFN-&ggr; Secretion Assay Do Not Induce Significant Graft-Versus-Host Reactions In Vitro

  2016cites this paper
• Third-Party-T-Zell-Spender: eine alternative Quelle virusspezifischer T-Zellen für die adoptive Immuntherapie

  2016cites this paper
• Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

  2016cites this paper
• Immunotherapy for viral and fungal infections

  2015cites this paper
• Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer.

  2015cites this paper
• Development of a cytokine-secreting-based assay for the identification, sorting and transcriptomic analysis of polyfunctional human T cells

  2015cites this paper
• Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells

  2014influential citation
• Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease.

  2014cites this paper
• Zakażenie wirusem cytomegalii u młodzieży jako czynnik ryzyka rozwoju przedklinicznej postaci miażdżycy

  2014cites this paper
• Multimer monitoring of CMV-specific T cells in research and in clinical applications.

  2014cites this paper
• Interaktion zytosolischer Peptidasen und deren Rolle bei der MHC-Klasse-I-Antigenpräsentation des HLA-A2-restingierten HCMV pp65495-503 Epitops

  2014cites this paper
• Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice

  2014cites this paper
• Timing of CMV‐specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation

  2014cites this paper
• Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry

  2013influential citation
• Peptidselektive Isolierung unmanipulierter T-Zellen für die adoptive Immuntherapie

  2013cites this paper
• Rapid Generation of EBV‐Specific Cytotoxic T Lymphocytes Resistant to Calcineurin Inhibitors for Adoptive Immunotherapy

  2013cites this paper
• Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes.

  2013cites this paper
• Novel approaches for the isolation and expansion of cytomegalovirus-specific T cells for adoptive immunotherapy

  2013cites this paper
• Selection of perforin expressing CD4+ adenovirus-specific T-cells with artificial antigen presenting cells.

  2013cites this paper
• Immunotherapy in invasive fungal infection--focus on invasive aspergillosis.

  2013cites this paper
• Engineering of T cell receptor genes to advance T cell therapy: studies into TCR pairing, signaling and binding strength

  2013cites this paper
• CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.

  2013cites this paper
• The T cell repertoire specific for the IE-1 protein of human cytomegalovirus

  2013cites this paper
• Immunosenescence and the 3Rs: Restoration, Replacement and Reprogramming

  2012cites this paper
• Magnetic-Activated Cell Sorting of TCR-Engineered T Cells, Using tCD34 as a Gene Marker, but Not Peptide–MHC Multimers, Results in Significant Numbers of Functional CD4+ and CD8+ T Cells

  2012cites this paper
• Characterization of the cellular immune responses to Rhizopus oryzae with potential impact on immunotherapeutic strategies in hematopoietic stem cell transplantation.

  2012cites this paper
• Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials

  2012cites this paper
• Targeting cytomegalovirus-infected cells using T cells armed with anti-CD3 × anti-CMV bispecific antibody.

  2012cites this paper
• Immunotherapy for fungal infections.

  2012cites this paper
• Sorting Through Subsets: Which T-Cell Populations Mediate Highly Effective Adoptive Immunotherapy?

  2012cites this paper
• Selective binding of CD4 and CD8 T-cells to antigen presenting cells for enrichment of CMV and HIV specific T-lymphocytes.

  2012cites this paper
• Induction of Thelper1-driven Antiviral T-cell Lines for Adoptive Immunotherapy Is Determined by Differential Expression of IFN-&ggr; and T-cell Activation Markers

  2012cites this paper
• Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes.

  2012cites this paper
• Infections and Organ Transplantation: New Challenges for Prevention and Treatment—A Colloquium

  2012cites this paper
• Successful generation of primary virus-specific and anti-tumor T-cell responses from the naïve donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells

  2011cites this paper
• Adoptive antifungal T cell immunotherapy--into the clinic?

  2011cites this paper
• Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantation.

  2011influential citation
• Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation.

  2011cites this paper
• Cells with dendritic cell morphology and immunophenotype, binuclear morphology, and immunosuppressive function in dendritic cell cultures.

  2011cites this paper
• Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequencies

  2011cites this paper
• Rapid detection, enrichment and propagation of specific T cell subsets based on cytokine secretion

  2011cites this paper
• Deletion mutant of human cytomegalovirus lacking US2-US6 and US11 maintains MHC class I expression and antigen presentation by infected dendritic cells.

  2011cites this paper
• Adoptive immunotherapy with virus-specific T cells.

  2011cites this paper
• Review Article Strategies to harness immunity against infectious patho- gens after haploidentical stem cell transplantation

  2011cites this paper
• Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans.

  2011cites this paper
• Simultaneous Isolation of CD8+ and CD4+ T Cells Specific for Multiple Viruses for Broad Antiviral Immune Reconstitution After Allogeneic Stem Cell Transplantation

  2011cites this paper
• Candida albicans and Aspergillus fumigatus 1 immunity against H Cross-protective T

  2011cites this paper
• Sources of diversity in T cell epitope discovery.

  2011cites this paper
• Maintenance and Restoration of Immune System Function

  2010cites this paper
• Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy

  2010cites this paper
• High Throughput T Epitope Mapping and Vaccine Development

  2010cites this paper
• Adoptive transfer of pp 65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

  2010cites this paper
• Immunotherapy against EBV-lymphoma in recipients of HSCT

  2010cites this paper
• Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update.

  2010cites this paper
• Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154.

  2010cites this paper
• Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.

  2010cites this paper
• Infektionen und Immuntherapie

  2010cites this paper
• Cytomegalovirus infection/disease after hematopoietic stem cell transplantation

  2010cites this paper
• Challenges and Prospects of Adoptive Immunotherapy in Prevention and Treatment of Opportunistic Mycoses in Hematologic Transplant Recipients

  2010cites this paper
• Multimer technologies for detection and adoptive transfer of antigen-specific T cells

  2010cites this paper
• Soluble Recombinant CMVpp65 Spanning Multiple HLA Alleles for Reconstitution of Antiviral CD4+ and CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation

  2010cites this paper
• T-cell therapy for cytomegalovirus infection

  2010cites this paper
• Isolating cytomegalovirus-specific T cells for adoptive transfer: are we there yet?

  2010cites this paper
• Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation

  2010cites this paper
• Generierung CMV-spezifischer Lymphozyten aus Stammzellapheresat

  2010cites this paper
• Adoptive Immunotherapy for Prophylaxis and Therapy of Infectious Complications After Allogeneic Hematopoietic Stem Cell Transplantation

  2010cites this paper
• Reconstitution immunitaire et immunothérapie adoptive anti-virales après allogreffe de cellules souches hématopoiétiques

  2010cites this paper
• Small but mighty: How the MACS®‐technology based on nanosized superparamagnetic particles has helped to analyze the immune system within the last 20 years

  2010cites this paper
• Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.

  2010cites this paper